Navigation Links
Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Date:10/18/2007

our ability to control or predict. See "Risk Factors" under "Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operation" from our Annual Report on Form 10-KSB for the year ended December 31, 2006, and other descriptions in the Company's public filings with the Securities and Exchange Commission for a discussion of such risks, including the Company's need for additional funds, the Company's dependence on a limited number of therapeutic compounds, the stage of the products the Company is developing, uncertainties relating to clinical trials and regulatory reviews, competition and dependence on collaborative partners, the Company's ability to avoid infringement of the patent rights of others, and the Company's ability to obtain adequate patent protection and to enforce these rights. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Avicena does not undertake any obligation to update or review any such forward-looking information, whether as a result of new information, future events or otherwise.

Contact:

The Ruth Group (on behalf of Avicena Group)

Sara Ephraim (investors)

(646) 536-7002

sephraim@theruthgroup.com

Janine McCargo / Jason Rando (media)

(646) 536-7033 / 7025

jmccargo@theruthgroup.com or jrando@theruthgroup.com


'/>"/>
SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
11. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... Aug. 21, 2014  SI-BONE, Inc. ( San ... pioneered the use of the iFuse Implant System, ® ... fusion of the sacroiliac (SI) joint, announced that Priority ... to its Lumbar Fusion Medical Policy No. 91590-R4 providing ... The policy states that the fusion procedure, which employs ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... MISSISSAUGA, Ontario, March 11, 2011 Valeant Pharmaceuticals ... VRX) announced that effective March 10, 2011, the ... S.A. About Valeant Valeant Pharmaceuticals ... pharmaceutical company that develops, manufactures and markets a ...
... (Nasdaq: OPTR ) today announced 2010 fourth quarter ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) Optimer reported a ... of $11.9 million, or $0.31 per common share, as compared ... common share, for the same period in 2009.  Optimer reported ...
Cached Medicine Technology:Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 2Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 3Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 4Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 5Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 6Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 7Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 8
(Date:8/21/2014)... 2014 American Addiction Centers, a leading ... individuals with drug and/or alcohol addiction, has been named ... Private Companies. , The company is ranked 7th on ... and 4th on the list in the “Nashville Metro ... 995%, American Addiction Centers (AAC) ascended to number 474 ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Sasha is a ... dog. Sasha is getting a little older, and is having ... But Sasha just happens to have an owner who purchased ... Judy had an accident, and could no longer get up ... to her finished basement. She had tried a stair ...
(Date:8/21/2014)... of Chest Physicians (CHEST) announces the immediate release ... During Pandemics and Disasters: CHEST Consensus Statement today ... CHEST while the global health-care community ... consensus statement aims to guide ethical decision-making, coordination ... The statement was developed by over 100 clinicians ...
(Date:8/21/2014)... NJ (PRWEB) August 21, 2014 ... leading Radiologists, Amish P. Patel, MD, and Sujoy ... system welcomes Dr. Patel and Dr. Menon to ... comprehensive array of diagnostic imaging services to patients ... Bayonne Medical Center, Christ Hospital and Hoboken University ...
(Date:8/21/2014)... SAN FRANCISCO, Aug. 21, 2014 Individuals with schizophrenia ... goals for themselves, and a new study from San ... difficulty in assessing the amount of effort required to ... published this week in the Journal of Abnormal ... deficits among patients with schizophrenia and help those patients ...
Breaking Medicine News(10 mins):Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2Health News:Sasha Gets a Butler Mobility Inclined Platform Lift 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2
... possible genetic cause for increased risk for a ... that leads to shorter survival, according to data ... journal of the American Association for Cancer Research. ... and differences in colorectal cancer incidence, aggressiveness and ...
... N.C. A recent discovery by researchers at Wake Forest ... new drug that inhibits tumor growth in cancer patients and ... discovery stems from a study, recently published in the ... United States of America, in which researchers looked at angiogenesis ...
... 31 Rheumatoid arthritis (RA) is a systemic disease ... system attacks the joints through the thin layer of ... joints. The most visible symptoms of RA are swollen ... feet. It can cause fatigue, fever, loss of appetite ...
... it is recalling Kroger Lite Mayo in 32-ounce plastic jars with ... Southwestern Ohio, including Cincinnati and Dayton, and in Northern Kentucky and ... illnesses have been reported in connection with the product. Kroger is ... , Kroger Lite Mayo sold ...
... As the United States prepares to reduce troop ... as 4.7 million displaced civilians in the region remain at ... strategy for addressing Iraq,s socioeconomic needs.In prepared remarks delivered Tuesday ... and South Asia, International Medical Corps President & CEO Nancy ...
... Corporation (NYSE: PRA ) announced today that the ... (PICA) have overwhelmingly approved the sponsored demutualization that will bring ... as a standalone subsidiary. The transaction, which requires final regulatory approval ... Illinois , is expected to close early in the second ...
Cached Medicine News:Health News:Blood protein may hold key to stopping tumor growth in cancer patients 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:In Testimony before Senate, International Medical Corps CEO Urges U.S. to Increase Support for Displaced Iraqis 2Health News:PICA Policyholders Approve ProAssurance Transaction 2Health News:PICA Policyholders Approve ProAssurance Transaction 3Health News:PICA Policyholders Approve ProAssurance Transaction 4Health News:PICA Policyholders Approve ProAssurance Transaction 5Health News:PICA Policyholders Approve ProAssurance Transaction 6
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
... and removal in the urinary tract. The nitinol ... shape following extreme torsion. The unique tipless design ... basket to open at the base of the ... reduces the likelihood of mucosal damage and perforation. ...
Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
Medicine Products: